1. Severe myocardial hypertrophy and fibrosis in a patient with acromegaly: is the prevention of sudden cardiac death needed?
- Author
-
A. A. Almaskhanova, K. V. Melkozerov, E. G. Przhiyalkovskaya, N. V. Tarbaeva, R. S. Kosharnaia, I. S. Gomova, P. A. Alferova, L. Ya. Rozhinskaya, V. Y. Kalashnikov, Zh. E. Belaya, G. A. Melnichenko, and N. G. Mokrysheva
- Subjects
acromegaly ,heart arrhythmia and conduction disorder ,cardiac magnetic resonance imaging ,acromegalic cardiomyopathy ,myocardial fibrosis ,myocardial hypertrophy ,Therapeutics. Pharmacology ,RM1-950 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
The most common causes of death in acromegaly are cardiovascular diseases (about 60%). Heart arrhythmias and conduction disorders lead to sudden cardiac death (SCD). In this article, we described a clinical case about preventing SCD in a patient with acromegaly. We identified in this patient predictors of SCD: severe left ventricular hypertrophy, the signs of myocardial fibrosis, decreased systolic function of the left ventricular myocardium, ventricular rhythm disturbances, and heart failure. Patients with acromegaly have higher risk of heart arrhythmias due to development acromegalic cardiomyopathy with includes: left ventricular hypertrophy, diastolic and systolic dysfunction, myocardial fibrosis and electrical disturbances of the myocardium. The main limitation is the lack of special clinical recommendations for the management of this group of patients. Current recommendations based on a standard algorithm and do not consider specificity of acromegalic cardiomyopathy.
- Published
- 2024
- Full Text
- View/download PDF